This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Freshpet (FRPT) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Freshpet (FRPT) and Philip Morris (PM) have performed compared to their sector so far this year.
United Natural Q4 Earnings Beat, UNFI Sales Rise on Unit Volume Hike
by Zacks Equity Research
UNFI's Q4 results reflect sales growth across all channels. The company is focused on creating value for customers and suppliers.
Are Consumer Staples Stocks Lagging Freshpet (FRPT) This Year?
by Zacks Equity Research
Here is how Freshpet (FRPT) and Henkel AG & Co. (HENKY) have performed compared to their sector so far this year.
Freshpet (FRPT) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
Freshpet (FRPT) closed at $141.24 in the latest trading session, marking a +0.23% move from the prior day.
Freshpet (FRPT) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the most recent trading session, Freshpet (FRPT) closed at $135.22, indicating a -0.91% shift from the previous trading day.
Beat the Market Like Zacks: CareDx, Fair Isaac, 3M in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
How Will the Sale of 51.8% Interest in Agro Tech Foods Aid CAG Stock?
by Zacks Equity Research
Conagra announces the completion of the divestiture of its 51.8% ownership stake in Agro Tech Foods that is set to enhance its portfolio.
Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?
by Zacks Equity Research
Sector ETF report for FXG
Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXG
Colgate (CL) Benefits From Innovation & Pricing Actions
by Zacks Equity Research
Colgate's (CL) margins benefit from robust pricing and funding-the-growth and other productivity initiatives.
Archer Daniels (ADM) & FBN Launch Gradable to Boost Technology
by Zacks Equity Research
Archer Daniels (ADM) and Farmers Business Network launch a joint venture, Gradable, to boost technology solutions.
Medifast (MED) Tumbles 25% in 3 Months: Should You Buy Now?
by Zacks Equity Research
Medifast (MED) is encountering difficulties in attracting customers due to a reduction in the number of active OPTAVIA Coaches and diminished productivity per Coach.
General Mills (GIS) Hurt by Volatile Consumer Trends, Cost Woes
by Zacks Equity Research
While brand strength and the Accelerate strategy aid General Mills (GIS), the challenging operating environment and cost-related hurdles keep the near term under pressure.
Newell (NWL) Stock Declines 22% in 3 Months: Can it Rebound?
by Zacks Equity Research
Newell (NWL) is battling uncertainties like a tough macroeconomic environment and elevated levels of core inflation, leading to soft discretionary demand and soft sales
Lamb Weston (LW) Down More Than 40% in 6 Months: Here's Why
by Zacks Equity Research
Lamb Weston (LW) is battling key issues like ongoing input cost inflation, persistent execution difficulties and a softening in global demand for frozen fries.
McCormick's (MKC) Solid Brands & Cost Savings Propel Growth
by Zacks Equity Research
McCormick's (MKC) commitment to achieving long-term objectives is evident from its proven track record and wide-reaching and competitive global portfolio with a focus on high-growth areas.
Conagra Brands (CAG) Fuels Portfolio With Sweetwood Smoke Buyout
by Zacks Equity Research
Conagra Brands' (CAG) acquisition of Sweetwood Smoke & Co. highlights its focus on expanding in the innovative, high-protein snacks category.
Freshpet (FRPT) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Freshpet (FRPT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Monster Beverage (MNST) Stock Down on Q2 Earnings & Sales Miss
by Zacks Equity Research
Monster Beverage (MNST) posts soft second-quarter 2024 results. Its Monster Energy Drinks segment's sales rise 3.3% year over year.
Pre-Markets Deep in Red, Sell-off in Global Markets Intensifies
by Zacks Equity Research
Pre-Markets Deep in Red, Sell-off in Global Markets Intensifies.
Freshpet (FRPT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Freshpet (FRPT) delivered earnings and revenue surprises of 66.67% and 1.87%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Can Molson Coors' (TAP) Strategies Outrun Inflation Woes in Q2?
by Zacks Equity Research
Molson Coors' (TAP) strategic investments and premiumization efforts drive robust growth amid industry challenges and inflationary pressures. Let us see how the Q2 performance is likely to have been.
Medifast (MED) Q2 Earnings in the Cards: Factors to Watch
by Zacks Equity Research
Medifast's (MED) Q2 results are likely to reflect customer acquisition challenges stemming from the growth of GLP-1 medications in markets.
Pilgrim's Pride (PPC) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Pilgrim's Pride's (PPC) second-quarter results reflect earnings and sales growth due to portfolio diversification strategies, operational excellence, branded offerings and key customer partnerships.
US Foods (USFD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
US Foods (USFD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.